Clinical Trial Update: Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the molecular signature of valproic acid in breast cancer with functional imaging has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University of Utah | Conditions: Cancer | Phase 1 | Status: TERMINATED